This issue of Surgical Clinics of North America focuses on The Pancreas Revisited, and is edited by Dr. Avram Cooperman. Articles will include: Is preclinical diagnosis / or prevention of cancer of the pancreas be possible?; Preoperative evaluation of a pancreas mass: diagnostic options; Clinical evaluation of a pancreatic mass: what is essential and practical from a therapeutic standpoint?; Screening of patients at risk for familial pancreatic cancer— what is beneficial?; Incidental IPMN, cystic /premalignant lesions of the pancreas: the case for selective, conservative management; Preoperative stenting for benign and malignant periampullary cancer: the case for selective application; Preoperative stenting for benign and malignant periampullary diseases: unnecessary if not harmful?; Timing of pancreatic resection and patient outcomes: is there a difference?; Outcome analysis for pancreatic surgery: actual vs actuarial methods?; The role of radiation in pancreatic cancer: the European and American view; Adjuvant or neoadjuvant therapy in the treatment in pancreatic malignancies: Where are we?; Nonoperative Ablation of Pancreatic Neoplasms; Incidental IPMN, cystic/ premalignant lesions of the pancreas: The case for aggressive management; Ex Vivo surgery for low grade tumors involving celiac and superior mesenteric arteries; and more!
1. Cover image - p. i 2. Title page - p. i 3. Table of Contents - p. i 4. Copyright - p. ii 5. Contributors - p. iii 6. Forthcoming Issues - p. xii 7. Foreword - p. xiii 8. Preface - p. xvii 9. Prevention and Early Detection of Pancreatic Cancer - p. 1 10. Preoperative Evaluation of a Pancreas Mass: Diagnostic Options - p. 13 11. Screening of Patients at Risk for Familial Pancreatic Cancer: What Is Beneficial? - p. 25 12. Preoperative Stenting for Benign and Malignant Periampullary Diseases: Unnecessary if Not Harmful - p. 37 13. A Tale of 2 Techniques: Preoperative Biliary Drainage and Routine Surgical Drainage with Pancreaticoduodenectomy - p. 49 14. Timing of Pancreatic Resection and Patient Outcomes: Is There a Difference? - p. 57 15. Cancer of the Pancreas—Actual 5, 10, and 20+Year Survival: The Lucky and Fortunate Few - p. 73 16. Rare, Uncommon, and Unusual Complications After Pancreaticoduodenal Resection - p. 87 17. Adjuvant or Neoadjuvant Therapy in the Treatment in Pancreatic Malignancies: Where Are We? - p. 95 18. The Evolving Role of Radiation in Pancreatic Cancer - p. 113 19. Nonoperative Ablation of Pancreatic Neoplasms - p. 127 20. Incidental Intraductal Papillary Mucinous Neoplasm, Cystic or Premalignant Lesions of the Pancreas: The Case for Aggressive Management - p. 141 21. Nonfunctioning Incidental Pancreatic Neuroendocrine Tumors: Who, When, and How to Treat? - p. 157 22. Rare Tumors and Lesions of the Pancreas - p. 169 23. Ex Vivo Resection and Autotransplantation for Pancreatic Neoplasms - p. 189
No hay muestra disponible
No hay ficha técnica disponible
This issue of Surgical Clinics of North America focuses on The Pancreas Revisited, and is edited by Dr. Avram Cooperman. Articles will include: Is preclinical diagnosis / or prevention of cancer of the pancreas be possible?; Preoperative evaluation of a pancreas mass: diagnostic options; Clinical evaluation of a pancreatic mass: what is essential and practical from a therapeutic standpoint?; Screening of patients at risk for familial pancreatic cancer— what is beneficial?; Incidental IPMN, cystic /premalignant lesions of the pancreas: the case for selective, conservative management; Preoperative stenting for benign and malignant periampullary cancer: the case for selective application; Preoperative stenting for benign and malignant periampullary diseases: unnecessary if not harmful?; Timing of pancreatic resection and patient outcomes: is there a difference?; Outcome analysis for pancreatic surgery: actual vs actuarial methods?; The role of radiation in pancreatic cancer: the European and American view; Adjuvant or neoadjuvant therapy in the treatment in pancreatic malignancies: Where are we?; Nonoperative Ablation of Pancreatic Neoplasms; Incidental IPMN, cystic/ premalignant lesions of the pancreas: The case for aggressive management; Ex Vivo surgery for low grade tumors involving celiac and superior mesenteric arteries; and more!
1. Cover image - p. i 2. Title page - p. i 3. Table of Contents - p. i 4. Copyright - p. ii 5. Contributors - p. iii 6. Forthcoming Issues - p. xii 7. Foreword - p. xiii 8. Preface - p. xvii 9. Prevention and Early Detection of Pancreatic Cancer - p. 1 10. Preoperative Evaluation of a Pancreas Mass: Diagnostic Options - p. 13 11. Screening of Patients at Risk for Familial Pancreatic Cancer: What Is Beneficial? - p. 25 12. Preoperative Stenting for Benign and Malignant Periampullary Diseases: Unnecessary if Not Harmful - p. 37 13. A Tale of 2 Techniques: Preoperative Biliary Drainage and Routine Surgical Drainage with Pancreaticoduodenectomy - p. 49 14. Timing of Pancreatic Resection and Patient Outcomes: Is There a Difference? - p. 57 15. Cancer of the Pancreas—Actual 5, 10, and 20+Year Survival: The Lucky and Fortunate Few - p. 73 16. Rare, Uncommon, and Unusual Complications After Pancreaticoduodenal Resection - p. 87 17. Adjuvant or Neoadjuvant Therapy in the Treatment in Pancreatic Malignancies: Where Are We? - p. 95 18. The Evolving Role of Radiation in Pancreatic Cancer - p. 113 19. Nonoperative Ablation of Pancreatic Neoplasms - p. 127 20. Incidental Intraductal Papillary Mucinous Neoplasm, Cystic or Premalignant Lesions of the Pancreas: The Case for Aggressive Management - p. 141 21. Nonfunctioning Incidental Pancreatic Neuroendocrine Tumors: Who, When, and How to Treat? - p. 157 22. Rare Tumors and Lesions of the Pancreas - p. 169 23. Ex Vivo Resection and Autotransplantation for Pancreatic Neoplasms - p. 189
No hay muestra disponible
No hay ficha técnica disponible
